22-44913977-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_138415.5(PHF21B):c.676C>T(p.His226Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000745 in 1,611,218 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138415.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHF21B | NM_138415.5 | c.676C>T | p.His226Tyr | missense_variant | 5/13 | ENST00000313237.10 | NP_612424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHF21B | ENST00000313237.10 | c.676C>T | p.His226Tyr | missense_variant | 5/13 | 1 | NM_138415.5 | ENSP00000324403.5 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151850Hom.: 0 Cov.: 29
GnomAD3 exomes AF: 0.0000240 AC: 6AN: 249748Hom.: 0 AF XY: 0.0000296 AC XY: 4AN XY: 135010
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1459368Hom.: 0 Cov.: 39 AF XY: 0.00000551 AC XY: 4AN XY: 726062
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151850Hom.: 0 Cov.: 29 AF XY: 0.0000539 AC XY: 4AN XY: 74152
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 11, 2022 | The c.676C>T (p.H226Y) alteration is located in exon 5 (coding exon 5) of the PHF21B gene. This alteration results from a C to T substitution at nucleotide position 676, causing the histidine (H) at amino acid position 226 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at